Kristoffer Månsson

Title: The Innovative Contributions of Kristoffer Månsson

Introduction

Kristoffer Månsson is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds and formulations. With a total of five patents to his name, Månsson's work has the potential to impact therapeutic practices significantly.

Latest Patents

Månsson's latest patents include Ingenol-3-acylates III and Ingenol-3-carbamates. These inventions relate to compounds of general formula I, wherein R is heteroaryl optionally substituted by R7, or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8. These compounds are designed for use in therapy, particularly for preventing, treating, or ameliorating diseases responsive to stimulation of neutrophil oxidative burst, keratinocyte IL-8 release, or induction of necrosis. Another patent, 3-acyl-ingenols II, also focuses on compounds of general formula I, where R can be aryl substituted by R3 or various cycloalkyl structures. These compounds are similarly aimed at therapeutic applications.

Career Highlights

Throughout his career, Månsson has worked with prominent companies in the pharmaceutical industry, including Leo Laboratories Limited and Leo Pharma A/S. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Månsson has collaborated with notable colleagues such as Xifu Liang and Thomas Högberg. These partnerships have likely facilitated the exchange of ideas and expertise, enhancing the quality and impact of his inventions.

Conclusion

Kristoffer Månsson's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic solutions.